CPT code 11901: Intralesional injection billing guide 2026

Key Takeaways

CPT code 11901 describes intralesional injection of a substance into more than 7 lesions in a single session

Use CPT 11900 for up to 7 lesions and CPT 11901 for more than 7; never bill both on the same date for the same patient

The drug itself (e.g. triamcinolone acetonide) is billed separately using HCPCS J3301 when payer policy permits separate reimbursement

Pabau’s claims management software helps dermatology and skin clinic teams track lesion counts, link drug codes, and reduce claim denials

CPT code 11901 is the procedure code for intralesional injection of a substance into more than 7 distinct lesions in a single patient encounter. It covers the injection service only; the drug administered is billed separately using a HCPCS Level II code such as J3301.

This guide covers the full billing picture for CPT 11901: the official code description, how it compares to 11900, the common drugs and HCPCS codes billed alongside it, current Medicare reimbursement guidance, applicable modifiers, documentation requirements, global period rules, and payer-specific prior authorization policies.

CPT code 11901: Definition and clinical description

CPT code 11901 is published by the American Medical Association (AMA) under the Introduction or Removal Procedures on Skin category. The official descriptor reads: Injection(s), intralesional; more than 7 lesions.

The code applies when a clinician injects a therapeutic substance directly into lesion tissue during a single patient encounter. The defining criterion is the lesion count: more than 7 lesions treated in that session. Common clinical scenarios include intralesional corticosteroids for keloid scars, alopecia areata, acne cysts, and inflammatory plaques.

See other CPT billing references on Pabau for comparison with procedure codes in other specialties.

The code does not specify the drug injected. It covers the injection service itself. The injected substance is billed separately using a HCPCS Level II drug code (see the J3301 section below).

11900 vs 11901: Choosing the correct code

The only clinical distinction between these two codes is the number of lesions injected. Bill 11900 for up to and including 7 lesions. Bill 11901 for 8 or more lesions. Never bill both codes together on the same date of service for the same patient; payers treat them as mutually exclusive.

For additional CPT code structure context, Pabau’s ADHD screening CPT codes guide illustrates how the AMA assigns codes within procedural categories across different specialties.

Lesion counting rules for CPT 11901

Count each anatomically distinct lesion separately. A single confluent plaque does not automatically count as multiple lesions. The chart note must document each lesion individually, including its anatomic location, to support the count you bill.

• Count by lesion, not by injection pass: if you inject two concentrations into the same lesion, that is still one lesion
• Bilateral lesions count separately: a keloid on each earlobe = 2 lesions
• Document the tally explicitly: “12 acne lesions injected on the face and chest” beats a generic reference to “multiple lesions”
• Threshold is 8, not 7: seven lesions = 11900; eight lesions = 11901

Common drugs billed with CPT code 11901

CPT code 11901 covers the injection service, not the drug. Providers must bill the drug separately using the appropriate HCPCS Level II code when the payer reimburses it distinctly. Triamcinolone acetonide (Kenalog) is the most frequently injected substance, but other agents are also used depending on the condition being treated.

HCPCS drug code J3301 and CPT 11901

J3301 describes triamcinolone acetonide, not elsewhere classified, 10 mg. One billing unit equals 10 mg. A provider administering 40 mg across 12 lesions bills 4 units of J3301 alongside CPT 11901.

Whether J3301 reimburses separately depends entirely on payer policy. Medicare Part B generally reimburses J3301 under the drug fee schedule when the drug is separately identifiable and documented. Many commercial payers bundle the drug into the procedure allowable and will not pay J3301 as an additional line item. Verify with each payer before billing routinely.

Pabau’s dermatology EMR software supports linked HCPCS drug codes within encounter documentation to reduce missed drug-code submissions.

CPT code 11901 reimbursement and fee schedule 2026

Medicare reimbursement for CPT 11901 is calculated using the Medicare Physician Fee Schedule (MPFS), which is updated annually by the Centers for Medicare and Medicaid Services (CMS). The national payment rate is derived from the code’s relative value units (RVUs) multiplied by the annual conversion factor.

The exact dollar allowable depends on the current-year conversion factor and the provider’s locality-specific Geographic Practice Cost Index (GPCI), both of which CMS updates annually. Facility-setting payment is lower than non-facility payment because CMS assumes the facility absorbs the practice expense costs.

Use the CMS fee schedule lookup tool to pull the current, locality-adjusted non-facility and facility allowable for CPT 11901 before quoting reimbursement to patients or practice leadership.

Commercial payer rates for CPT 11901 vary considerably by contract. Rates typically fall in the range of 110-160% of Medicare allowable for in-network dermatology providers, though contracts differ. Use the FastRVU 2026 lookup tool to model rates across different conversion factors and localities.

Modifiers for CPT code 11901

Modifier use for CPT code 11901 is one of the more common sources of audit risk. Using the wrong modifier, or omitting one that is required, often triggers a denial or post-payment review. Pabau’s claims management software flags modifier conflicts during charge entry to catch these before submission.

Modifier 25 attaches to the E&M code, not to 11901. The injection procedure code stands alone. The E&M must represent a decision-making encounter that is distinct from the injection itself; a brief injection note alone does not support a separately billed E&M.

Documentation requirements for intralesional injection billing

Payers and auditors routinely deny CPT 11901 claims when chart notes fail to support the lesion count. Strong documentation is the foundation of clean claims for intralesional injection billing. Practices using digital intake forms can pre-populate structured fields for lesion location and count before the provider even opens the chart.

Every chart note for 11901 should include:

• Exact lesion count: “12 lesions injected” not “multiple lesions”
• Anatomic site(s): specific location for each lesion or group (e.g. “8 lesions on the scalp vertex, 4 on the occipital scalp”)
• Substance injected: drug name, concentration, and total dose administered
• Medical necessity: clinical indication linking the diagnosis (ICD-10 code) to the treatment decision
• Patient response or prior treatment note: particularly important for repeat sessions and payers requiring proof of ongoing need
• Provider signature: with credentials and date of service

The same logic applies when tracking diagnostic codes such as ICD-10 code M34.2 across multiple specialties: structured note templates reduce the risk of missing required fields. A generic SOAP note without explicit lesion-count documentation will not withstand a payer audit.

Common billing errors and how to avoid them

Claim denials for CPT 11901 follow predictable patterns. Most derive from lesion-count errors, missing drug codes, or bundling violations. Reviewing denial EOBs against these categories lets billing teams identify systemic issues rather than treating each denial as a one-off.

• Wrong lesion count code: billing 11901 for 7 or fewer lesions is upcoding. Auditors compare the code to chart documentation. A lesion count of 7 in the note but 11901 on the claim triggers recoupment.
• Missing J3301 (or other HCPCS drug code): the procedure code alone does not capture the drug expense. Payers that reimburse the drug separately will deny the claim if the HCPCS code is absent.
• Unbundling same-date dermatologic procedures: billing 11901 alongside CPT 17110 (destruction of benign lesions, up to 14 lesions) on the same date without a valid modifier 59/XS typically triggers an NCCI edit. Documented clinical justification is required.
• Missing modifier 25 on same-day E&M: billing an E&M without modifier 25 when it accompanies 11901 leads to automatic bundling.
• Inadequate medical necessity: payers with coverage policies for intralesional injections (particularly for alopecia areata or acne) require a documented diagnosis linked to a covered ICD-10 code.

Accurate medical coding follows the same logic for procedure codes like CPT 11102: if the chart cannot support the code, the code cannot survive a review. See also Pabau’s guide to CPT 11450 for parallel documentation principles in dermatologic billing.

Bundling rules and NCCI edits for CPT 11901

The CMS National Correct Coding Initiative (NCCI) edits define which codes cannot be billed together without a modifier. CPT 11901 has several column-two bundling edits with same-day dermatologic services. Modifier 59 (or the more specific X-modifier) can override these edits only when the procedures are truly distinct and separately documented.

• NCCI edits are updated quarterly; review the current CMS NCCI tables before assuming an edit is inactive
• Modifier 59 overrides require documentation that the procedures were performed on a different anatomic site, during a separate session, or involved a distinct condition
• Routine modifier 59 use without clinical justification is a red flag in post-payment audits

Global period for CPT code 11901

CPT code 11901 carries a 000-day global period, based on the CMS MPFS database classification for minor procedures of this type. A 000-day global period means there is no preoperative or postoperative period included in the procedure payment. Every day, including the date of service, is a clean slate for billing.

For skin clinics, this has two practical implications. First, a follow-up visit the next day for an injection-related concern can be billed as a separate E&M, without modifier appended, because the global period does not encompass post-procedure care.

Second, same-day E&M services that are significant and separately identifiable from the injection still require modifier 25 on the E&M code. The 000-day period does not remove that requirement.

Verify the global period assignment via the CMS MPFS lookup tool before relying on any figure from a third-party source; payers sometimes apply their own global period interpretations that differ from Medicare’s 000-day assignment. Skin clinic practice management platforms that integrate billing and scheduling can flag follow-up visits falling within global periods across multiple procedure types.

Payer-specific policies for CPT 11901

Medicare and commercial payer policies for intralesional injections differ enough that a one-size-fits-all billing approach regularly produces denials. Med spa compliance requirements reflect the same reality: federal baselines rarely capture the full payer-by-payer picture.

• Prior authorization: some commercial payers (particularly managed Medicaid plans) require prior authorization for intralesional injections for alopecia areata or certain off-label indications. Medicare does not require prior auth for 11901, but advantage plans may. Verify before each encounter for new indications.
• Frequency limits: several major insurers limit intralesional corticosteroid injections to a set number of sessions per 12-month period per condition. Exceeding these limits without documentation of medical necessity results in automatic denial.
• Coverage criteria by indication: intralesional 5-fluorouracil for keloids is covered by some payers and excluded by others. Bleomycin for warts may require documentation of failed first-line treatments. Check the payer’s local coverage determination (LCD) or medical policy before billing.
• Drug reimbursement carve-outs: some commercial payers carve J3301 into the facility payment or into a global capitated payment. Calling the payer’s provider line to confirm drug billing rules before submitting claims avoids administrative rework.

Streamline your dermatology billing with Pabau

Pabau helps dermatology and skin clinic teams link CPT procedure codes to HCPCS drug codes, apply modifiers automatically, and track claim status without manual spreadsheet chasing. See how it fits your billing workflow.

Book a demo

Related CPT codes for dermatologic procedures

CPT 11901 does not exist in isolation. Dermatology and aesthetic practices routinely encounter these codes in the same billing context. Understanding how each code relates to 11901 prevents inadvertent unbundling and missed coding opportunities. Pabau’s procedure code fee schedule guide covers related code families across multiple billing systems.

Conclusion

The most common CPT 11901 denials share one root cause: documentation that cannot support the lesion count billed. Eight lesions is the threshold, and every one of them needs to be individually documented with an anatomic location and the substance injected.

Pabau’s practice management software gives dermatology and aesthetic teams a structured framework for linking CPT procedure codes, HCPCS drug codes, and ICD-10 diagnoses within the same encounter record, reducing the manual reconciliation that leads to claim errors.

London Face and Skin Clinic made this kind of consolidation part of switching to Pabau, moving patient records, consent forms, and billing into one system, as described in this case study. To see how that fits your workflow, book a demo.

Continue your research

Need a full dermatology billing workflow? Pabau’s dermatology EMR software connects procedure coding, charting, and claims management in one platform.

Looking for IVF procedure code references? IVF CPT codes covers the full procedure code set for fertility billing, including modifier and documentation guidance.

Want to understand HIPAA-compliant billing practices? Pabau’s HIPAA compliance guide outlines the documentation and data-handling standards that intersect with billing workflows.

Frequently asked questions